BLCO (Bausch + Lomb Corporation) Utang jangka cendhak marang modal

Bausch + Lomb Corporation (BLCO) generates revenue through the sale of ophthalmology products, including eye care supplies and surgical instruments. The comprehensive infrastructure they have established integrates vitamins and lenses, setting a quality benchmark for medical professionals. The current metric stands at 0.01, which clearly demonstrates the stock price trend of the company on the GURU.Markets platform.

To assess the long-term sustainability of Bausch + Lomb Corporation (BLCO), it is essential to analyze the ratio of current liabilities to equity, which helps identify risks of cash flow gaps and excessive interest payments. By examining this chart of current liabilities to equity, an investor can see how liquidity depends on the inertial demand for ophthalmology consumables, which provides a stable cash flow to service current loans.